Stay updated on Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial

Sign up to get notified when there's something new on the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page gains links to additional study documents and related metadata (consent form addenda, the protocol and SAP, IPD plan, and publications), expanding reference materials for investigators and potential participants.
    Difference
    54%
    Check dated 2026-08-16T15:47:47.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5. This reflects a minor maintenance update rather than a substantive change to study content or features.
    Difference
    0.1%
    Check dated 2026-08-09T10:00:35.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3, reflecting a newer build or patch.
    Difference
    0.1%
    Check dated 2026-07-25T23:27:14.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a small internal update to the page's metadata. The visible content and study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-04T13:32:09.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2 instead of Revision: v3.6.0. This indicates a minor software update to the page's underlying implementation.
    Difference
    0.1%
    Check dated 2026-06-27T06:37:15.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The page now communicates that recruitment has ended and introduces new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also changes the labeling of the intervention section from 'Intervention / Treatment' to 'Intervention/Treatment' and updates the page revision to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T00:26:22.000Z thumbnail image

Stay in the know with updates to Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page.